French pine bark extract may help manage symptoms of fibromyalgia, says recent study
A recent study found that supplementation with French pine bark extract helped manage symptoms of fibromyalgia.
Photo © iStockphoto.com/J-Elgaard
A recent study1 found that supplementation with French pine bark extract (Pycnogenol from Horphag Research; Hoboken, NJ) helped manage symptoms of fibromyalgia. In the study, 50 female patients with idiopathic fibromyalgia were assigned to receive Pycnogenol with standard management or standard management alone for four weeks. None of the subjects were taking any drugs, and all of the subjects have elevated levels of oxidative stress at inclusion.
Results showed that the percentage of patients taking NSAIDS as rescue medication was significantly higher in the standard management group compared to the group taking Pycnogenol. The same was true for the use of corticosteroids. Subjects taking Pycnogenol also demonstrated a significant reduction in symptoms and complaints compared to standard management alone.
More specifically, subjects taking Pycnogenol saw improvements in the following symptoms:
- 54% decrease in the number of subjects with stiffness pain (vs 17% in the control group)
- 58% reduction in the number of subjects with widespread pain (vs 38% in the control group)
- 58% reduction in the number of subjects with pain that worsens with fatigue (vs 14% in the control group)
- 54% decrease in the number of subjects with fatigue (vs 21% in the control group)
- 55% reduction in the number of subjects with mental cloudiness (vs 5% in the control group)
- 71% decrease in the number of subjects with IBS symptoms (vs 8% in the control group)
- 100% decrease in the number of subjects with interstitial cystitis symptoms (vs 25% in the control group)
- 64% reduction in the number of subjects with migraines (vs 20% in the control group)
- 63% reduction in the number of subjects with headaches (vs 13% in the control group)
- 70% decrease in the number of subjects with occurrences of paresthesia (vs 14% in the control group)
- 35% decrease in the number of subjects with perceived stress levels (vs 5% in the control group)
Reference
- Belcaro G et al. “Idiopathic myalgic pain (fibromyalgia): supportive management and prevention with Pycnogenol®.” Panminerva Medica, vol. 63, no. 1 (2021): 46-50
New review from BAPP estimates adulteration of five popular botanicals
September 10th 2024The study focused on the adulteration of black cohosh rhizome, echinacea root or herb, elder berry, ginkgo leaf, and turmeric root/rhizome. The authors reviewed 78 publications with a total of 2995 samples. Of the 2995 samples, 818 were reported to be adulterated or mislabeled.
PLT Health Solution's Bosewellia serrata extract granted updated license by Health Canada
August 27th 2024The Natural and Non-Prescription Health Products Directorate (NNPHD) of Health Canada has granted PLT Health Solutions an updated license to market its AprèsFlex 5-Day Joint Support Ingredient in Canada.
Sirio Pharma launches line of ready-to-market organic gummies and softgels called PureOrganix
August 26th 2024The new line is made up of three gummies and one softgel that are formulated to meet stringent EU-Organic certification criteria, and target women’s health, metabolic health, and heart health.
